Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Another flash crash
View:
Post by ScienceFirst on Jun 14, 2023 3:52pm

Another flash crash

To 0.255$, when the last trade was at 0.29$.  A bit like last time.

No stress.  Thin ASK at 0.27$ now.
Comment by DJDawg on Jun 14, 2023 4:18pm
Flash crash came from the US side. A dump of around 200k shares in the space of a minute. When this happens it usually has to be offloaded to the Canadian side. I always find those dumps odd as there is no logic EXCEPT to bring price down. Anyone else would sell in smaller parcels to try and get the most dollars for the shares. I've always suspected that it is the same entity or person who ...more  
Comment by Sunvalley on Jun 14, 2023 4:18pm
Picked another 1000 shares at 0.27 just for the fun of it after the mini flash crash. Had some loose change sitting in my account. If you lay back in the weeds and await these opportunities it makes for a fun time. That is , if you have the time to spare , which I happen to have today. Got to practice what I preach when I say "buy the dips". A thousand  shares here,  a few ...more  
Comment by Beano349 on Jun 14, 2023 4:20pm
I have been doing this for a few months, on the US side, couple bucks every time its under .20
Comment by ScienceFirst on Jun 14, 2023 4:28pm
IBRX (1.3B$US) has 30x our market valuation.  They way more trials ongoing but they were valued a bit higher and they are still awaiting their first FDA approval for our current population (BCG-unresponsive).  But as a combo and BCG dependent.  They already had a big pharma agreement ongoing (most probably MERCK because of their dependence with BCG).  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250